PFE•benzinga•
Pfizer Reveals Encouraging Data From Pivotal Bladder Cancer Trial
Summary
Pfizer's Phase 3 CREST trial results highlight the efficacy of sasanlimab combined with BCG in treating high-risk non-muscle invasive bladder cancer.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 10, 2025 by benzinga